FDA Overhauls Guidance On Speedier Drug Approvals
The U.S. Food and Drug Administration on Thursday finalized criteria describing how drugmakers can utilize a quartet of expedited approval pathways for medications addressing unmet needs for serious conditions, revising a...To view the full article, register now.
Already a subscriber? Click here to view full article